Obesema 2.4mg Injection

Obesema 2.4 mg Injection – Semaglutide for Chronic Weight Management

Obesema 2.4 mg Injection is a prescription pre-filled injection pen containing Semaglutide 2.4 mg per dose. It is used together with a reduced-calorie diet and increased physical activity to support chronic weight management in eligible adults. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps regulate appetite, reduce hunger, increase feelings of fullness, and support lower food intake. Each multidose disposable pen contains 9.6 mg of semaglutide in 3 mL and provides four fixed doses of 2.4 mg. The 2.4 mg strength is generally used as a maintenance dose after gradual dose escalation and should not be used as the initial treatment dose.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 2.4 mg Per Dose: Each prescribed injection delivers 2.4 mg of semaglutide.
• Four-Dose Pen: Each multidose disposable pen provides four weekly doses.
• Supports Weight Management: Helps regulate appetite and reduce calorie intake.
• Once-Weekly Administration: Designed for use on the same day each week.
• Subcutaneous Injection: Administered under the skin of the abdomen, thigh, or upper arm.
• Maintenance Strength: The 2.4 mg dose is reached only after gradual dose escalation.

Active Ingredient

• Semaglutide 2.4 mg per dose

Uses

• Chronic weight management in eligible adults with obesity.
• Supporting weight loss when combined with a reduced-calorie diet and increased physical activity.
• Supporting long-term maintenance of reduced body weight under medical supervision.

How to Use

• Inject one prescribed dose once weekly on the same day each week.
• It may be administered at any time of the day, with or without food.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with every weekly dose.
• Attach a new compatible needle before each injection.
• Check that the solution is clear and colourless before use.
• Remove and safely discard the needle immediately after every injection.

Precautions

• Obesema 2.4 mg is a maintenance strength and should be reached only through the prescribed dose-escalation schedule.
• Nausea, vomiting, and diarrhoea may cause dehydration. Maintain adequate fluid intake unless medically restricted.
• The risk of low blood sugar may increase when semaglutide is used with insulin or sulfonylurea medicines.
• People with diabetes should promptly report sudden or worsening changes in vision.
• Inform healthcare professionals that you use semaglutide before surgery, general anaesthesia, or deep sedation.
• Do not combine it with another semaglutide medicine or GLP-1 receptor agonist unless specifically directed
• Seek immediate medical assistance for facial swelling, breathing difficulty, fainting, or another serious allergic reaction.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or heartburn.
• Abdominal bloating or increased gas.
• Headache.
• Dizziness.
• Fatigue.
• Injection-site redness, itching, or irritation.
• Low blood sugar when used with certain diabetes medicines.
• Gallstones or gallbladder inflammation.

Storage

• Before first use, store the pen in a refrigerator between 2°C and 8°C.
• Do not freeze or use a pen that has been frozen.
• Keep the pen away from the refrigerator’s cooling element.
• Keep it in its original packaging to protect it from light.
• Keep the pen cap attached when the pen is not being used.
• Do not store the pen with a needle attached.
• Keep out of the sight and reach of children.

Legal Disclaimer: Obesema 2.4 mg Injection is a prescription semaglutide medicine and a maintenance-dose strength. It should be used only after gradual dose escalation and under the supervision of a qualified healthcare professional. The prescribing doctor must determine eligibility, dose selection, treatment duration, and continued use. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the original instructions supplied with the medicine.